Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Current Assets:    
Cash and cash equivalents $ 24,907,963 $ 24,782,128
Accounts receivable, net 2,291,533 1,373,754
Other receivables 526,070  
Prepaid expenses and other current assets 495,178 107,651
Total Current Assets 28,220,744 26,263,533
Intangible assets, net 2,946,610 1,071,850
Goodwill 463,000  
Property and equipment, net 44,756 17,166
Deferred offering costs 10,000 10,000
Total Assets 31,685,110 27,362,549
Current Liabilities:    
Accounts payable - suppliers 1,844,544 336,028
Accounts payable - trade 659,362 1,106,604
Accrued expenses and other current liabilities 2,493,287 1,017,282
Deferred revenue 395,914 15,000
Notes payable 151,336 218,461
Total Current Liabilities 5,544,443 2,693,375
Contingent consideration 613,000  
Notes payable, non-current portion 77,407 187,629
Total Liabilities 6,234,850 2,881,004
Commitments and contingencies (Note 9)
Stockholders' Equity :    
Preferred stock, $0.00001 par value; 5,000,000 shares authorized; No shares issued and outstanding as of December 31, 2021 and 2020
Common stock, $0.00001 par value; 95,000,000 shares authorized; 14,253,948 and 11,756,109 shares issued and outstanding as of December 31, 2021 and 2020 respectively 143 118
Additional paid-in capital 52,030,907 40,770,504
Accumulated deficit (26,580,790) (16,289,077)
Total Stockholders' Equity 25,450,260 24,481,545
Total Liabilities and Stockholders' Equity $ 31,685,110 $ 27,362,549